Navigation Links
In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn
Date:3/23/2009

Lower-Than-Expected Patient Volumes Seen in Houston Physician-Owned Hospitals, According to New Reports from HealthLeaders-InterStudy

NASHVILLE, Tenn., March 23 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while Texas laws favoring physicians have traditionally enabled doctors practicing in the state to compete directly with health systems, these regulations may actually yield increasing challenges for this sector. According to the recent Houston Market Overview and San Antonio Market Overview, positives for the physician sector are tempered by economic conditions and a challenging contracting environment.

Texas has no certificate-of-need requirements for healthcare facilities and state law bars hospitals from employing physicians in most cases--two factors that have allowed doctors to build their own hospitals and facilities. There are more physician-owned hospitals in Texas than in any other state.

Meanwhile, the current economic environment finds many patients delaying care, a situation that will intensify as more consumers adopt health plans with higher copays and deductibles.

In the Houston market, home to more than a dozen acute-care facilities with physician investors, the area's physician-owned hospitals have an additional challenge: difficulty securing managed care contracts. Physician-owned University General Hospital and Foundation Surgical Hospital have contracts with one major insurer each--Aetna and UnitedHealth, respectively. Each hospital has seen lower-than-expected patient volumes.

"The Houston market has seen many hospitals open in recent years. For physician-owned facilities, today's environment, with reduced patient volumes and limited managed care contracts, makes it difficult for them to become profitable," said Mark Cherry, market analyst with HealthLeaders-InterStudy. "In areas like Houston and San Antonio we'll likely see physicians begin to work more closely with health systems, and consolidation among the overall health system segment as these players look to become more efficient."

Why Pharmaceutical Companies Need Market Overviews

Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas, allowing pharmaceutical executives to quickly gain local area expertise. Each report provides local-level insights into: health systems and hospitals, physicians, health plans, Medicare/Medicaid, pharmaceutical environment, legislation and employers.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Lisa Osgood                      Elizabeth Marshall
    HealthLeaders-InterStudy         Decision Resources, Inc.
    781-296-2606                     781-296-2563
    losgood@hl-isy.com               emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
2. Austin, Texas, Physicians Second in Nation to Perform New Procedure for Difficult-to-Treat Atrial Fibrillation Cases
3. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
4. Some drug studies more likely to have favorable conclusions
5. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
6. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
7. INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
8. Memry Corporation Plans to Appeal Unfavorable Court Result
9. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
10. Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
11. Non-parental care of infants tied to unfavorable feeding practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... Center for ... for caregivers of those affected by autism spectrum disorder (ASD) and other developmental disabilities. ... Seals Maine, will give parents and other caregivers the opportunity to share stories and ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... U.S. Surgeon ... interview with Mediaplanet, Dr. Murthy explains how he was inspired to practice medicine at ... learned that medicine is about more than making diagnoses and prescribing medicine,” he states. ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of two ostomy patients, standing as living proof that attitude and determination can ... diseases and issues that spike around the holidays. This campaign will offer patients ...
(Date:12/2/2016)... ... 02, 2016 , ... More than half of American teens report losing their ... speaking with their child about sex related topics, less than 60 percent spoke about ... to announce the launch of its second edition of the “Sexual Wellness” campaign, aiming ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, ... through labeling, storing, shipping and disposal. The new version is a faster and ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 Persistence Market Research ... its upcoming report titled, "Global Market Study on Cardiac Pacemaker: ... of -1.4% between 2016 and 2024". The global cardiac pacemaker ... and this is likely to decline to US$ 3923.8 ... cardiac pacemaker market is anticipated to exhibit a declining ...
(Date:12/2/2016)... December 2, 2016 According ... Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology ... Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to ... valued at USD 60.22 Billion in 2016. This ... of 5.5% during the forecast period (2016-2021) to ...
(Date:12/2/2016)... , Dec. 2, 2016  The Addiction Treatment ... Academy of Managed Care Pharmacy (AMCP), has released ... better address the opioid addiction crisis, including through ... (MAT). ATAG,s newly released paper, "The ... to Naloxone," addresses many issues around gaps and ...
Breaking Medicine Technology: